vancomycin has been researched along with carbostyril in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 26 (50.98) | 18.2507 |
2000's | 13 (25.49) | 29.6817 |
2010's | 10 (19.61) | 24.3611 |
2020's | 2 (3.92) | 2.80 |
Authors | Studies |
---|---|
Fenoll, A; López de Felipe, F; Martínez-Suárez, JV; Rodríguez-Tudela, JL | 1 |
Watanabe, A | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Handwerger, S; Mildvan, D; Shonekan, D | 2 |
Bailey, EM; Kaatz, GW; Lamp, KC; Rybak, MJ; Seo, SM | 1 |
Cars, O; Löwdin, E; Odenholt-Tornqvist, I | 1 |
Kanno, H | 1 |
Hessen, MT; Kaye, D; Pitsakis, PG | 1 |
Cagni, A; Chuard, C; Lew, DP; Schrenzel, J; Vaudaux, PE | 1 |
Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ | 1 |
Giamarellou, H | 1 |
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Hiramatsu, K; Hori, S | 1 |
Tsuji, A | 1 |
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
Arai, T; Kinoshita, T; Nimura, N | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM | 1 |
Biedenbach, DJ; Johnson, DM; Jones, RN; Marshall, SA | 1 |
Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK | 1 |
Blard, JM; Finiels, PJ; Khoris, J; Milhaud, D; Pagès, M; Privat, JM | 1 |
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T | 1 |
Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L | 1 |
Ghaffar, F; Hardy, RD; Iglehart, J; McCracken, GH; Michelow, IC; Olsen, K; Rodriguez-Cerrato, V; Saavedra, J | 1 |
Ferber, D | 1 |
Barton, T; Bowlware, K; Hardy, RD; Iglehart, J; Katz, K; McCoig, CC; McCracken, GH; Michelow, IC; Rodriguez-Cerrato, V; Saavedra, J | 1 |
Lowy, FD | 1 |
Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Miyazaki, Y; Murata, I; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
Jones, RN; Kirby, JT; Sader, HS; Walsh, TR | 1 |
Di, JH; Shen, XZ; Yang, YH | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Flatz, L; Kühn, F; Müller, HP; Pfister, M; Stucki, A | 1 |
Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H | 1 |
Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Appelbaum, PC; Credito, K; Lin, G | 1 |
Galanakis, E; Maraki, S; Samonis, G | 1 |
Medico, CJ; Walsh, P | 1 |
Fondelli, S; Iacopi, E; Leonildi, A; Menichetti, F; Piaggesi, A; Rizzo, L; Tagliaferri, E; Tascini, C; Tedeschi, A | 1 |
Dasgupta, A | 1 |
Akamatsu, Y; Baba, T; Hiramatsu, K; Igarashi, M; Morimoto, Y; Umekita, M | 1 |
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
Deierhoi, RJ; Graham, LA; Hawn, MT; Henderson, WG; Itani, KM; Richman, JS; Vick, CC | 1 |
Baud, D; Greub, G; Vouga, M | 1 |
Awosile, B; German, G; Heider, LC; McClure, JT; Rodriguez-Lecompte, JC; Saab, ME | 1 |
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
ALanazi, AG; Ali, I; ALOthman, ZA; Suhail, M | 1 |
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
8 review(s) available for vancomycin and carbostyril
Article | Year |
---|---|
Empiric therapy for infections in the febrile, neutropenic, compromised host.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Immunocompromised Host; Lactams; Mycoses; Neutropenia; Quinolones; Sulfamethoxazole; Time Factors; Trimethoprim; Vancomycin; Virus Diseases | 1995 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
Antimicrobial resistance: the example of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Penicillins; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Progresses in molecular biologic studies on coagulase negative staphylococcus infection].
Topics: Bacteremia; Catheterization; Child; Coagulase; Cross Infection; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Methicillin; Quinolones; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections; Vancomycin | 2004 |
[Antibiotics and overweight].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin | 2005 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Advances in antibiotic measurement.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Chloramphenicol; Chromatography; Humans; Immunoassay; Macrolides; Penicillins; Quinolones; Sulfonamides; Vancomycin | 2012 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
1 trial(s) available for vancomycin and carbostyril
Article | Year |
---|---|
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin | 1999 |
42 other study(ies) available for vancomycin and carbostyril
Article | Year |
---|---|
Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cerebrospinal Fluid; Daptomycin; Erythromycin; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Quinolones; Serotyping; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1992 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Depsipeptides; Enterococcus faecalis; Fluoroquinolones; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1992 |
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Kidney; Male; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rabbits; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Roxithromycin; Streptococcus pneumoniae; Streptococcus pyogenes; Vancomycin | 1992 |
[Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disinfectants; Humans; Lactams; Macrolides; Methicillin Resistance; Postoperative Complications; Quinolones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Vancomycin | 1990 |
Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Fluoroquinolones; Male; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Foreign Bodies; Guinea Pigs; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
[Mechanisms of antimicrobial resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Macrolides; Methicillin Resistance; Quinolones; Staphylococcus aureus; Vancomycin | 1994 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Investigation of enantioselective separation of quinolonecarboxylic acids by capillary zone electrophoresis using vancomycin as a chiral selector.
Topics: Anti-Infective Agents; Electrophoresis, Capillary; Fluoroquinolones; Ofloxacin; Quinolones; Stereoisomerism; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin | 1996 |
Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Vancomycin | 1995 |
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin | 1997 |
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin | 1998 |
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin | 1998 |
[Epidural and intramedullary abscess of acute onset].
Topics: 4-Quinolones; Abscess; Anti-Infective Agents; Drug Therapy, Combination; Epidural Space; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxacillin; Pefloxacin; Quinolones; Spinal Cord Diseases; Vancomycin | 1998 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin | 2001 |
BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporin Resistance; Fluoroquinolones; Indoles; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Vancomycin | 2001 |
Antibiotic resistance. Livestock feed ban preserves drugs' power.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Europe; Feces; Fluoroquinolones; Glycopeptides; Humans; Quinolones; Swine; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance; Virginiamycin | 2002 |
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Indoles; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2003 |
Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood-Borne Pathogens; Injections, Intraperitoneal; Lung; Lung Diseases; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2003 |
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
Topics: Anti-Infective Agents; beta-Lactam Resistance; Chryseobacterium; Humans; Microbial Sensitivity Tests; Quinolones; Vancomycin | 2004 |
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Kinetics; Meninges; Meningitis, Pneumococcal; Mutation; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin | 2004 |
Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Male; Methicillin; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Pyrrolidines; Quinolones; Specific Pathogen-Free Organisms; Staphylococcus aureus; Vancomycin | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
Topics: Acetamides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2007 |
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Chloramphenicol; Clindamycin; Greece; Heptavalent Pneumococcal Conjugate Vaccine; History, 21st Century; Humans; Immunization Programs; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumococcal Vaccines; Quinolones; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccines, Conjugate; Vancomycin | 2010 |
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
Topics: Anti-Infective Agents; Candida; Diabetic Foot; Doxycycline; Enterococcus; Enterococcus faecalis; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2011 |
Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
Topics: Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Quinolones; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2012 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
Timing of surgical antibiotic prophylaxis and the risk of surgical site infection.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefazolin; Digestive System Surgical Procedures; Female; Humans; Hysterectomy; Male; Middle Aged; Quinolones; Retrospective Studies; Risk Factors; Surgical Wound Infection; Time Factors; Vancomycin; Vascular Surgical Procedures | 2013 |
Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Chlamydiaceae Infections; Chlamydiales; Chlorocebus aethiops; Clindamycin; Macrolides; Microbial Sensitivity Tests; Quinolones; Rifampin; Vancomycin; Vero Cells | 2017 |
Determination of antimicrobial resistance to extended-spectrum cephalosporin, quinolones, and vancomycin in selected human enteric pathogens from Prince Edward Island, Canada.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Humans; Prince Edward Island; Quinolones; Vancomycin | 2018 |
HPLC enantio-separation and chiral recognition mechanism of quinolones on vancomycin CSP.
Topics: Chromatography, High Pressure Liquid; Limit of Detection; Linear Models; Quinolones; Reproducibility of Results; Stereoisomerism; Vancomycin | 2020 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |